Stock Preachers News Comments

Vancouver, British Columbia, October 14th / PRNewswire / -- The stock market weakened during the week, with the Nasdaq Composite Index falling by 449 points, a decrease of 1.65%, to 26,755.24 points, extending its weekly decline to 2.23%. The S&P 500 Index fell by 1.10% on that day, with a cumulative decline of 1.18% for the week; the Russell 2000 Index fell by 1.70%, and its Relative Strength Index ( RSI ) was only 28.3, indicating that small-cap stocks are in a state of deep oversold. The Dow Jones Industrial Average performed relatively well, falling by 0.29%. Gold fell by 1.93%, silver fell by 5.81%, while WTI crude oil rose against the trend by 1.36%, to $95.42 per barrel.

Companies active in the market this week include: RTX ( NYSE : RTX ), Lockheed Martin ( NYSE : LMT ), Eli Lilly and Company ( NYSE : LLY ), Alimentation Couche - Tard Inc ( TSX : ATD ), and IBM ( NYSE : IBM ).

The overall decline in the stock market caused all major stock indices to close lower this week, with the Nasdaq experiencing the largest weekly drop of 2.23%. The S&P 500 index is currently slightly above its 50-day simple moving average support level of 7,707.03 points, while the Dow Jones Industrial Average is trading near its 20-day SMA support level of 51,489.97 points; both are on the edge of short-term technical support.

Volatility has increased, but it remains within a controllable range. VIX has risen by 0.95 points to 16.22, and VXN has risen to 21.14. Both indicators are still within the recent weekly ranges, indicating that although the RSI of the Russell 2000 is at 28.3, showing that small-cap stocks are under pressure earlier than the broader market, the selling has not yet triggered panic-level hedging demand.

Commodity trends have diverged. WTI Crude oil rose by 1.36% on the day, and has increased by 66.18% since the beginning of the year, in sharp contrast to gold which fell by 1.93% and silver which fell by 5.81%; silver has already fallen by 20.54% since the start of the year. The yield on 10-year U.S. Treasury bonds rose by 3 basis points to 5.25%, and the euro weakened against the dollar by 0.33%.

The complete report lists the support and resistance levels for each index, the highlights of various sectors, as well as the key areas that traders should focus on in the second half of this week.

This week, the market indeed exhibited a seesaw trend. For more news about these companies and other sectors, please refer to: https :// stockpreachers.com / articles / energy-and-pharma-hold-the-fort-as-tech-takes-it-on-the-chin /

Other industry developments and updates in the market this week include:

RTX ( NYSE : RTX ) Raytheon (a business under RTX) has secured a five-year contract with an additional two-year option, worth up to $6.3 billion, for the production and maintenance of Standard Missile-3 Block IB interceptors. This contract is part of a recent agreement between Raytheon and the Ministry of War, aimed at replenishing missile defense stocks used in combat.

Production will mainly be carried out at the Raytheon factories in Tucson, Arizona, and Huntsville, Alabama. Raytheon President Phil Jasper stated: "This award highlights Raytheon's commitment to increasing the production of critical ammunition, ensuring that our customers have the necessary defense capabilities when needed."

Lockheed Martin ( NYSE : LMT ) Lockheed Martin has introduced new PAC-3 Edge interceptors, designed to counter hypersonic and advanced missile threats, as part of the U.S. Army's future interceptor missile program. The company will advance research and development and begin testing in 2027, with the goal of achieving rapid deployment by 2031.

PAC-3 Edge utilizes guidance heads developed by the Strigo Product Center under Lockheed Martin, which has received an investment of 250 million dollars. It is also equipped with multi-pulse solid rocket engines designed by Northrop Grumman. Tim Cahill, President of Lockheed Martin's Missile and Fire Control Division, stated: "Lockheed Martin's PAC-3 Edge interceptors are based on proven-in-action PAC-3 MSE, providing enhanced maneuverability, power, and speed, ensuring that the Army's layered defense architecture continues to remain world-leading."

Eli Lilly and Company （ NYSE : LLY ） Eli Lilly announced new exploratory data from the Phase 3b trial of TOGETHER-PsO. This trial evaluated the combination of Taltz and Zepbound compared to using Taltz alone in adults with moderate to severe plaque psoriasis accompanied by obesity. By week 36, the combination therapy group showed changes in 482 differently expressed proteins, while the Taltz monotherapy group had 140; there were 467 and 16 differently expressed genes respectively.

According to the company's release, approximately 61% of psoriasis patients are also obese or overweight and have at least one weight-related complication. Mark Genovese, Senior Vice President of Development at Eli Lilly Immunology, Ph.D., stated: "The broader biomarker changes observed in Taltz and Zepbound, including those related to skin clearance, may indicate a meaningful relationship between immune and metabolic biology."

Alimentation Couche - Tard Inc. ( TSX : ATD ) Alimentation Couche - Tard has reached a final agreement with Irving Oil to acquire its retail assets in Quebec and Ontario, including 50 retail locations that are already operating under the Quebec Alliance framework, two locations in Ontario owned by Pembroke and Cornwall, as well as to supply fuel to 71 locations in Quebec that are owned and operated by Couche-Tard.

The transaction also includes 18 cardlock locations, of which 16 are located in Quebec and 2 are in Ontario; existing Irving Oil fleet customers will continue to receive services under long-term agreements. Alimentation Couche - Tard Senior Vice President of Operations, Stephane Trudel, stated: "This agreement is built on our long-term partnership with Irving Oil as well as our experience in operating these locations." The transaction must meet customary delivery conditions and obtain regulatory approval, including approval under the Competition Act.

IBM ( NYSE : IBM ) IBM announces its selection for Phase C of the DARPA Quantum Benchmark Testing Program ( Quantum Benchmarking Initiative ), which is the third phase, and has entered the independent verification process to test quantum hardware, systems engineering, and architecture, with the aim of advancing the development of fault-tolerant quantum computers.

DARPA launched this initiative in 2024 with the aim of determining whether it is possible to build a fault-tolerant quantum computer that can be used in industry by 2033. The director of the research department, who is also IBM Fellow Jay Gambetta, stated: "We expect to deliver the first fault-tolerant system in 2029, and we also plan to continue to expand the value of quantum computing beyond this timeline."

Contact Information:

https :// stockpreachers.com

Media contact: [ email protected ]